Federal grants to New York Blood Center, Inc
New York Blood Center, Inc in New York, New York received $41.5 million in federal grants from fiscal 2021 to 2025, across 25 awards. Its largest program was Cardiovascular Diseases Research, with $28.5 million. In fiscal 2025 it was awarded $8.4 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$41.5 million
- Awards25
- Awarded in FY 2025$8.4 million
- Largest award$15.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 13 | $10.3 million |
| FY 2022 | 9 | $8.4 million |
| FY 2023 | 8 | $7.5 million |
| FY 2024 | 9 | $6.9 million |
| FY 2025 | 13 | $8.4 million |
Programs that fund New York Blood Center, Inc
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 10 | $28.5 million |
| Allergy and Infectious Diseases Research | 8 | $8.0 million |
| Mental Health Research Grants | 4 | $3.0 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $1.1 million |
| Arthritis, Musculoskeletal and Skin Diseases Research | 1 | $675,351 |
| Trans-NIH Research Support | 1 | $170,800 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 25 | $41.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Complications of hemolysis and transfusion therapy | Cardiovascular Diseases Research | July 26, 2021 | $15.4 million |
| Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination - project abstract infectious diseases are a major cause of morbidity and mortality in the expanding older population. While vaccines are efficient measures to prevent infections, a critical problem is that aging- | Allergy and Infectious Diseases Research | July 29, 2021 | $3.7 million |
| Immune pathophysiology of sickle cell disease - project abstract a chronic inflammatory state is now considered a hallmark of sickle cell disease (SCD) resulting from ongoing hemolytic insult to the underlying vasculature and repeated cycles of vaso-occlusion crisis (VOC). Transfusions remain a corn | Cardiovascular Diseases Research | February 25, 2022 | $3.6 million |
| Hormetic er stress regulation of hematopoietic stem cell function - project summary hematopoiesis involves the continuous production of red blood cells (erythrocytes), immune cells (leukocytes) and blood clotting platelets over the lifespan of the subject all of which are derived from hematopoietic | Cardiovascular Diseases Research | June 24, 2021 | $2.5 million |
| Transfusion-driven hyperhemolysis in sickle cell disease - red blood cell (RBC) transfusions remain a cornerstone treatment in the management of sickle cell disease (SCD). However, patients may experience delayed hemolytic transfusion reaction (DHTR) which in this patient population has an unpredict | Cardiovascular Diseases Research | August 10, 2023 | $2.4 million |
| Neighborhoods, networks, and the HIV care continuum among hiv-infected msm in nyc | Mental Health Research Grants | January 26, 2021 | $1.8 million |
| Design of inhibitors targeted to the CD4 binding site on HIV-1 GP120 | Allergy and Infectious Diseases Research | January 7, 2021 | $1.6 million |
| Latexin function in the maintenance and regeneration of the hematopoietic system | Cardiovascular Diseases Research | June 11, 2021 | $1.6 million |
| Program project: red cell membrane studies | Diabetes, Digestive, and Kidney Diseases Extramural Research | August 16, 2021 | $1.1 million |
| Transfusion-driven hyperhemolysis in sickle cell disease - red blood cell (RBC) transfusions remain a cornerstone treatment in the management of sickle cell disease (SCD). However, patients may experience delayed hemolytic transfusion reaction (DHTR) which in this patient population has an unpredict | Cardiovascular Diseases Research | September 13, 2022 | $803,749 |
Questions people ask
How much federal grant money does New York Blood Center, Inc get?
$41.5 million in 25 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives New York Blood Center, Inc the most?
The Department of Health and Human Services, with $41.5 million in 25 awards.
What is New York Blood Center, Inc's largest federal grant?
$15.4 million under Cardiovascular Diseases Research, with its first action in the period on July 26, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund New York Blood Center, Inc?
Its largest are Cardiovascular Diseases Research, Allergy and Infectious Diseases Research and Mental Health Research Grants.
Other grant recipients in New York
- Metropolitan Transportation Authority
- New York City Housing Authority
- Gateway Development Commission
- The Trustees of Columbia University in the City of New York
- Icahn School of Medicine at Mount Sinai
- New York University
- Inclusiv, Inc
- International Rescue Committee, Inc.
Largest federal grant recipients in New York · Federal grants in New York